The forkhead transcription factor FOXO4 sensitizes cancer cells to doxorubicin-mediated cytotoxicity

Carcinogenesis

Volumn 29, Issue 11, 2008, Pages 2045-2052

  Lüpertz, Regine ^a   Chovolou, Yvonni ^a   Unfried, Klaus ^b   Kampkötter, Andreas ^b   Wätjen, Wim ^a   Kahl, Regine ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; DNA; DOXORUBICIN; FORKHEAD TRANSCRIPTION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR FOXO4; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE; CELL STRAIN HCT116; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DRUG SENSITIZATION; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MUTANT; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; WILD TYPE;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; DOXORUBICIN; HUMANS; MAP KINASE KINASE 4; OXIDATIVE STRESS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 56049096242     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn184     Document Type: Article

References (39)

1. Singal,P.K. et al. (1998) Doxorubicin-induced cardiomyopathy. N. Engl. J. Med., 339, 900-905.
2. Gewirtz,D.A. (1999) A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol., 57, 727-741.
3. Navarro,R. et al. (2006) Doxorubicin-induced MAPK activation in hepatocyte cultures is independent of oxidant damage. Ann. N. Y. Acad. Sci., 1090, 408-418.
4. Chovolou,Y. et al. (2007) Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis. Toxicology, 232, 89-98.
5. Wang,S. et al. (2004) Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of H(2)O(2)- and p53-dependent pathways. J. Biol. Chem., 279, 25535-25543.
6. Yu,H.G. et al. (2007) Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int. J. Cancer, 122, 433-443.
7. Testa,J.R. et al. (2001) AKT plays a central role in tumorigenesis. Proc. Natl Acad. Sci. USA, 98, 10983-10985.
8. Manning,B.D. et al. (2007) AKT/PKB signaling: Navigating downstream. Cell, 129, 1261-1274.
9. Blanco-Aparicio,C. et al. (2007) PTEN, more than the AKT pathway. Carcinogenesis, 28, 1379-1386.
10. O Wan,X. et al. (2007) PTEN augments doxorubicin-induced apoptosis in PTEN-null Ishikawa cells. Int. J. Gynecol. Cancer, 17, 808-812.
11. van der, H.A. et al. (2007) Stressing the role of FoxO proteins in lifespan and disease. Nat. Rev. Mol. Cell Biol., 8, 440-450.
12. Morris,B.J. (2005) A forkhead in the road th longevity: The molecular basis of lifespan becomes clearer. J. Hypetens., 23, 1285-1309.
13. Kampkotter,A. et al. (2008) Increase of stress resistance and lifespan of Caenorhabditis elegans by quercetin. Comp. Biochem. Physiol. B. Biochem. Mol. Biol., 149, 314-323.
14. Reagan-Shaw,S. et al. (2007) The role of Forkhead-box class O (FoXO) transcription factors in cancer: A target for the management of cancer. Toxicol. Appl. Pharmacol., 224, 360-368.
15. Arden,K.C. (2006) Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer. Exp. Gerontol., 41, 709-717.
16. Paik,J.H. et al. (2007) FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell, 128, 309-323.
17. Katoh,M. et al. (2004) Human FOX gene family (review). Int. J. Oncol., 25, 1495-1500.
18. Huang,H. et al. (2007) Dynamic FoxO transcription factors. J. Cell Sci., 120, 2479-2487.
19. Matsuzaki,H. et al. (2005) Regulation of intracellular localization and transcriptional activity of FOXO4 by protein kinase B through phosphorylation at the motif sites conserved am ng the FOXO family. J. Biochem. (Tokyo), 138, 485-491.
20. Essers,M.A. et al. (2004) FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 23, 4802-4812.
21. Li,S. et al. (2007) Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Mol. Cancer Ther., 6, 1031-1038.
22. Alexia,C. et al. (2006) Pleiotropic effects of PI-3' kinase/Akt signaling in human hepatoma cell proliferation and drug-induced apoptosis. Ann. N. Y. Acad. Sci., 1090, 1-17.
23. Mosmann,T. (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
24. Lupertz,R. et al. (2007) Catalase overexpression impairs TNF-alpha induced NF-kappaB activation and sensitizes MCF-7 cells against TNF-alpha. J. Cell Biochem, 103, 1497-1511.
25. Dorn,S.B. et al. (2008) Induction of micronuclei in V79 cells by the anabolic doping steroids tetrahydrogestrinone and trenbolone. Arch. Toxicol., 82, 257-263.
26. Fukuoka,M. et al. (2003) Negative regulation of forkhead transcription factor AFX (Foxo4) by CBP-induced acetylation. Int. J. Mol. Med., 12, 503-508.
27. Takeuchi,K. et al. (2004) Suppression of adriamycin-induced apoptosis by sustained activation of the phosphatidylinositol-3'-OH kinase-Akt pathway. J. Biol. Chem., 279, 892-900.
28. Hortobagyi,G.N. (1997) Anthracyclines in the treatment of cancer. An overview. Drugs, 54 (suppl 4), 1-7.
29. Rittierodt,M. et al. (2003) Repetitive doxorubicin treatment of glioblastoma enhances the PGP expression - a special role for endothelial cells. Exp. Toxicol. Pathol., 55, 39-44.
30. Puhlmann,U. et al. (2005) Impact of the cyclooxygenase system on doxorubicin-induced functional multidrug resistance 1 overexpression and doxorubicin sensitivity in acute rhyeloid leukemic HL-60 cells. J. Pharmacol. Exp., Ther., 312, 346-354.
31. Kuninaka,S. et al. (2000) Suppression of manganese superoxide dismutase augments sensitivity to radiation, hyperthermia and doxorubicin in colon cancer cell lines by inducing apoptosis. Br. J. Cancer, 83, 928-934.
32. Ueno,M. et al. (2006) Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo. J. Pharmacol. Sci., 101, 151-158.
33. Kalivendi,S.V. et al. (2005) Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: Role of mitochondrial reactive oxygen species and calcium. Biochem. J., 389, 527-539.
34. Micheau,O. et al. (1999) Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J. Biol. Chem., 274, 7987-7992.
35. Wagner,B.A. et al. (2005) Doxorubicin increases intracellular hydrogen peroxide in PC3 prostate cancer cells. Arch. Biochem. Biophys., 440, 181-190.
36. Kawamori,D. et al. (2006) The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J. Biol. Chem., 281, 1091-1098.
37. Zhao,Y. et al. (2004) Distinctive regulation and function of PI 3K/Akt and MAPKs in doxorubicin-induced apoptosis of human lung adenocarcirroma. cells. J. Cell. Biochem., 91, 621-632.
38. Greer,E.L. et al. (2005) FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene, 24 7410-7425.
39. Li,X. et al. (2005) Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells. Breast Cancer Res., 7, R589-R597.